Eur Rev Med Pharmacol Sci 2019; 23 (7): 2847-2855

DOI: 10.26355/eurrev_201904_17562

MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2

X.-Y. Shi, H. Wang, W. Wang, Y.-H. Gu

Department of Acupuncture, Taizhou Hospital Affiliated to Nanjing University of Chinese Medicine, Taizhou, China. gyh5196411@163.com


OBJECTIVE: The aim of this study was to explore the mechanism of miR-98-5p in influencing the malignant proliferation and metastasis capacities of breast cancer cells.
PATIENTS AND METHODS: Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was used to detect the expression level of miR-98-5p and GRB2-associated-binding protein 2 (Gab2) in breast cancer samples and cells. On-line target gene prediction software and Dual-Luciferase reporter assay were used to predict and verify the target genes of miR-98-5p, respectively. Cell proliferation was measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. Meanwhile, migration and invasion abilities, as well as the changes of epithelial-mesenchymal transition (EMT) after transfection were detected by transwell assay and Western blot assay, respectively.
RESULTS: Compared with adjacent non-tumor tissues and MCF-10A cells, the expression level of miR-98-5p in tumor tissues and MCF-7 cells was significantly declined, whereas Gab2 was markedly up-regulated. Besides, Gab2 was predicted as a target gene of miR-98-5p. Subsequent experiments indicated that the proliferation, migration, invasion and EMT of MCF-7 cells transfected with miR-98-5p were significantly inhibited. However, up-regulation of Gab2 attenuated the biological function of miR-98-5p on malignant abilities of breast cancer cells.
CONCLUSIONS: We showed that miR-98-5p served as anti-oncogene in breast cancer, which might provide a new therapeutic target for its treatment.

Free PDF Download

To cite this article

X.-Y. Shi, H. Wang, W. Wang, Y.-H. Gu
MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 7
Pages: 2847-2855
DOI: 10.26355/eurrev_201904_17562